查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1641804

全球酵母萃取物市场按类型、应用和形式划分 - 机会分析和产业预测（2024-2035 年）

Yeast Extract Market By Type (Yeastolate, Yeast Extracts, Active Dry Yeast), By Application (Pharmaceuticals, Biotechnology), By Form (Liquid, Dry): Global Opportunity Analysis and Industry Forecast, 2024-2035
出版日期: | 出版商: Allied Market Research | 英文 250 Pages | 商品交期: 2-3个工作天内

价格
简介目录

酵母萃取物市场

酵母萃取物市场 - IMG1

2023 年全球酵母萃取物市场价值为 4.409 亿美元，预计到 2035 年将达到 10.383 亿美元，2024 年至 2035 年的复合年增长率为 7.5%。

酵母萃取物是从酵母（通常是酿酒酵母）的细胞内容物中获得的天然成分。酵母细胞经由自溶、酵素处理等过程分解，可溶性成分则浓缩成糊状、粉末状或液体形式。该萃取物含有维生素、蛋白质、胺基酸、β-聚葡萄糖和核苷酸，具有丰富的营养素。

酵母萃取物酵母萃取物物丰富的营养成分使其成为生物製药领域生产各种药物的必需成分。因此，生物製药领域的扩张是酵母萃取物市场的主要驱动力。此外，由于酵母萃取物可作为天然的增味剂，消费者对洁净标示产品的倾向限制了食品和饮料中人工香料的添加，从而促进了市场的成长。由于酵母萃取物具有显着的营养价值，因此作为畜禽、水产饲料的补充剂使用已成为一种显着趋势。酵母萃取物可提高饲料转换率并增强牲畜的免疫力。

然而，大规模生产酵母萃取物是一个昂贵的过程，因为它需要专门的设备和优质的发酵过程原料。这限制了价格敏感产业的酵母萃取物采购，抑制了市场发展。相反，由于酵母萃取物发酵符合废弃物减少和永续回收方法，因此人们对循环经济的认识不断提高有望为市场提供有利可图的机会。酵母萃取物可透过酿造和烘焙行业的产品线轻鬆获得，从而促进永续性并减少对环境的影响。根据联合国的报告，采用循环经济方式预计到2050年将都市固态废弃物量从每年45亿吨以上减少到20亿吨以下。因此，酵母萃取物物的工业化生产可望降低其整体价格，并开闢新的市场通路。

部分回顾

酵母萃取物市场根据类型、应用、形式和地区进行细分。根据类型，市场分为酵母盐、酵母萃取物和活性酵母。从应用角度来看，可分为製药业和生技业。此外，製药部门分为疫苗生产、益生菌、抗生素生产和生物製药。生物技术部门分为细胞培养基和酵素生产。根据形式，市场分为液态和干态。依照地区，分析分为北美洲（美国、加拿大、墨西哥）、欧洲（法国、德国、义大利、西班牙、英国、俄罗斯和其他欧洲国家地区）、亚太地区（中国、日本、印度、韩国、澳洲和其他亚太地区）以及拉丁美洲、中东和非洲（巴西、南非、沙乌地阿拉伯、阿联酋、阿根廷和其他拉丁美洲、中东和非洲）。

主要发现

根据类型，活性酵母在 2023 年占据了市场主导地位。

根据应用，製药业在 2023 年的市场上占据显着地位。

从类型来看，干货板块在2023年成为第一大股东。

按地区划分，预计欧洲将在 2023 年创造最高收益。

相关人员的主要利益

本报告定量分析了市场细分、当前趋势、估计和趋势分析、2023 年至 2035 年酵母萃取物市场分析的动态，并确定了主要的酵母萃取物机会。

它为市场研究提供与市场驱动因素、市场限制因素和市场机会相关的资讯。

波特五力分析强调了买家和供应商的潜力，使相关人员能够做出利润驱动的商业决策并加强供应商-买家网络。

详细分析酵母萃取物市场细分，以确定市场机会。

每个地区的主要国家都根据收益贡献进行划分。

市场公司的定位有利于基准化分析，并能清楚了解市场公司的当前地位。

报告包括区域和全球酵母萃取物市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

本报告中提供的自订功能

  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的额外分析 - 市场规模和预测

目录

第 1 章 简介

第 2 章执行摘要

第三章 市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 驱动程式
      • 生物製药产业的成长
      • 生物技术进步
      • 提高生物加工的产量比率和品质
    • 限制因素
      • 生产成本高
      • 监管障碍
    • 机会
      • 新兴市场扩张
      • 个性化医疗的应用

第四章酵母萃取物市场（按类型）

  • 概述
  • 酵母菌
  • 酵母萃取物
  • 活性酵母

第五章酵母萃取物市场（依应用）

  • 概述
  • 药品
    • 药用酵母萃取物市场（依亚型划分）
  • 生物技术
    • 生物技术酵母萃取物市场（依亚型划分）

第六章酵母萃取物市场（依形式）

  • 概述
  • 液体
  • 烘干

第七章酵母萃取物市场（按地区）

  • 概述
  • 北美洲
    • 北美药用酵母萃取物市场（依亚型）
    • 北美生物技术酵母萃取物市场（依亚型）
    • 美国
    • 美国药用酵母萃取物市场（依亚型）
    • 美国生物技术酵母萃取物市场（按亚型）
    • 加拿大
    • 加拿大药用酵母萃取物市场（依亚型）
    • 加拿大生物技术酵母萃取物市场（按亚型）
    • 墨西哥
    • 墨西哥药用酵母萃取物市场（依亚型）
    • 墨西哥生物技术酵母萃取物市场（按亚型）
  • 欧洲
    • 欧洲药用酵母萃取物市场（依亚型）
    • 欧洲生物技术酵母萃取物市场（依亚型）
    • 法国
    • 法国药用酵母萃取物市场依亚型划分
    • 法国生物技术酵母萃取物市场（依亚型）
    • 德国
    • 德国药用酵母萃取物市场依亚型划分
    • 德国生物技术酵母萃取物市场（依亚型）
    • 义大利
    • 义大利药用酵母萃取物市场（依亚型）
    • 义大利生物技术酵母萃取物市场（依亚型）
    • 西班牙
    • 西班牙药用酵母萃取物市场（依亚型）
    • 西班牙生物技术酵母萃取物市场（依亚型）
    • 英国
    • 英国药用酵母萃取物市场（依亚型）
    • 英国生物技术酵母萃取物市场（按亚型）
    • 俄罗斯
    • 俄罗斯药用酵母萃取物市场依亚型划分
    • 俄罗斯生物技术酵母酵母萃取物市场（依亚型）
    • 其他的
    • 其他欧洲国家药用酵母萃取物市场（依亚型划分）
    • 其他欧洲国家生物技术酵母萃取物市场（依亚型划分）
  • 亚太地区
    • 亚太地区药用酵母萃取物市场（依亚型）
    • 亚太生物技术酵母萃取物市场（依亚型）
    • 中国
    • 中国药用酵母萃取物市场依亚型划分
    • 中国生物技术酵母萃取物市场（依亚型）
    • 日本
    • 日本药用酵母萃取物市场依亚型划分
    • 日本生物技术酵母萃取物市场（依亚型）
    • 印度
    • 印度药用酵母萃取物市场（依亚型）
    • 印度生物技术酵母萃取物市场（依亚型）
    • 韩国
    • 韩国药用酵母萃取物市场（依亚型）
    • 韩国生物技术酵母萃取物市场（依亚型）
    • 澳洲
    • 澳洲药用酵母萃取物市场（依亚型）
    • 澳洲生物技术酵母酵母萃取物市场（按亚型）
    • 其他的
    • 亚太地区其他地区药用酵母萃取物市场（依亚型划分）
    • 亚太地区其他生物技术酵母萃取物市场（依亚型划分）
  • 拉丁美洲、中东和非洲 (LAMEA)
    • LAMEA医药酵母萃取物市场（依亚型）
    • LAMEA生物技术酵母萃取物市场（依亚型）
    • 巴西
    • 巴西药用酵母萃取物市场（依亚型）
    • 巴西生物技术酵母萃取物市场（依亚型）
    • 南非
    • 南非药用酵母萃取物市场（依亚型划分）
    • 南非生物技术酵母萃取物市场（依亚型）
    • 沙乌地阿拉伯
    • 沙乌地阿拉伯药用酵母萃取物市场（依亚型）
    • 沙乌地阿拉伯生物技术酵母萃取物市场（按亚型）
    • 阿拉伯联合大公国（UAE）
    • 阿联酋医药酵母萃取物市场（依亚型）
    • 阿联酋生物技术酵母萃取物市场（依亚型）
    • 阿根廷
    • 阿根廷药用酵母萃取物市场（依亚型）
    • 阿根廷生物技术酵母萃取物市场（依亚型）
    • 其他LAMEA
    • 其他LAMEA医药酵母萃取物市场（按子类型划分）
    • 其他LAMEA生物技术酵母萃取物市场（按亚型）

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10主要企业的产品映射
  • 竞争仪錶板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • LESAFFRE GROUP
  • Kerry Group
  • Lallemand Inc.
  • AngelYeast Co., Ltd.
  • Associated British Foods PLC
  • Thermo Fisher Scientific Inc.
  • VWR International, LLC.
  • Merck KGaA
  • CELLSECO LTD.
  • FUJIFILM Irvine Scientific
  • Nu-Tek BioSciences
简介目录
Product Code: A06568

Yeast Extract Market

Yeast Extract Market - IMG1

The global yeast extract market was valued at $440.9 million in 2023 and is projected to reach $1,038.3 million by 2035, registering a CAGR of 7.5% from 2024 to 2035.

Yeast extract is a natural component derived from the cellular content of yeasts, generally Saccharomyces cerevisiae. The yeast cells are broken down through processes such as autolysis or enzymatic treatment and their soluble components are concentrated into a paste, powder, or liquid form. The extract exhibits a rich nutritional profile as it comprises vitamins, proteins, amino acids, beta-glucans, and nucleotides.

The rich nutritional profile of yeast extract has made it a critical ingredient in the biopharmaceutical sector for the production of different medications. Therefore, the expansion of the biopharmaceutical sector is a significant driver of the yeast extract market. In addition, the inclination of consumers toward clean-label products is augmenting the market growth as yeast extract serves as a natural flavor enhancer, thus limiting the addition of artificial flavors in food & beverages. Due to its remarkable nutritional value, the usage of yeast extract as a supplement in the feed of livestock, poultry, and aquatic organisms has become a prominent trend. The extract helps to improve the feed conversion ratios of animals and enhances their immunity.

However, large-scale production of yeast extract is an expensive process as it requires specialized equipment for fermentation processes and good quality raw materials. This limits the purchase of the extract in price-sensitive sectors, hence restraining the market development. On the contrary, rise in awareness regarding circular economy is projected to present lucrative opportunities for the market as the fermentation of yeast extract aligns with the waste reduction and sustainable development approaches. Yeast extract is easily attainable from the byproducts of the brewing or baking industry, hence promoting sustainability and reducing environmental impact. According to a report by the United Nations, the adoption of circular economy approach is anticipated to reduce the volume of municipal solid waste from more than 4.5 billion tons a year to less than 2 billion tons by 2050. Therefore, the production of yeast extract by industrial byproducts is projected to reduce its overall prices and open new avenues for the market.

Segment Review

The yeast extract market is segmented into type, application, form, and region. By type, the market is divided into yeastolate, yeast extracts, and active dry yeast. According to application, it is bifurcated into pharmaceuticals and biotechnology. Further, the pharmaceuticals segment is divided into vaccine production, probiotics, antibiotic production, and biopharmaceuticals. The biotechnology segment is segregated into cell culture media and enzyme production. As per form, the market is classified into liquid and dry. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (France, Germany, Italy, Spain, UK, Russia, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, UAE, Argentina, and rest of LAMEA).

Key Findings

By type, the active dry yeast segment dominated the market in 2023.

According to application, the pharmaceuticals segment acquired a notable stake in the market in 2023.

As per form, the dry segment was the highest shareholder in 2023.

Region wise, Europe was the highest revenue generator in 2023.

Competition Analysis

The major players in the yeast extract market include AngelYeast Co., Ltd., Associated British Foods PLC, CELLSECO LTD., FUJIFILM Irvine Scientific, Kerry Group, Lallemand Inc., LESAFFRE GROUP, Merck KGaA, Nu-Tek BioSciences, Thermo Fisher Scientific Inc., and VWR International, LLC. These major players have adopted various key development strategies such as acquisition, agreement, collaboration, joint venture, partnership, and product launch to strengthen their foothold in the competitive market.

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the yeast extract market analysis from 2023 to 2035 to identify the prevailing yeast extract market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the yeast extract market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global yeast extract market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast

Key Market Segments

By Form

  • Liquid
  • Dry

By Type

  • Yeastolate
  • Yeast Extracts
  • Active Dry Yeast

By Application

  • Pharmaceuticals
    • Sub-type
    • Vaccine Production
    • Probiotics
    • Antibiotic Production
    • Biopharmaceuticals
  • Biotechnology
    • Sub-type
    • Cell Culture Media
    • Enzyme Production

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa,
    • Saudi Arabia
    • UAE
    • Argentina
    • Rest of LAMEA

Key Market Players:

    • LESAFFRE GROUP
    • Lallemand Inc.
    • Associated British Foods PLC
    • CELLSECO LTD.
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Nu-Tek BioSciences
    • Kerry Group
    • VWR International, LLC.
    • FUJIFILM Irvine Scientific
    • AngelYeast Co., Ltd.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Growing Biopharmaceutical Industry
      • 3.4.1.2. Advancements in Biotechnology
      • 3.4.1.3. Improved Yield and Quality in Bioprocessing
    • 3.4.2. Restraints
      • 3.4.2.1. High Production Cost
      • 3.4.2.2. Regulatory Hurdles
    • 3.4.3. Opportunities
      • 3.4.3.1. Expansion in Emerging Markets
      • 3.4.3.2. Application in Personalized Medicine

CHAPTER 4: YEAST EXTRACT MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Yeastolate
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Yeast Extracts
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Active Dry Yeast
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: YEAST EXTRACT MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Pharmaceuticals
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
    • 5.2.4. Pharmaceuticals Yeast Extract Market by Sub-type
      • 5.2.4.1. Vaccine Production Market size and forecast, by region
      • 5.2.4.2. Vaccine Production Market size and forecast, by country
      • 5.2.4.3. Probiotics Market size and forecast, by region
      • 5.2.4.4. Probiotics Market size and forecast, by country
      • 5.2.4.5. Antibiotic Production Market size and forecast, by region
      • 5.2.4.6. Antibiotic Production Market size and forecast, by country
      • 5.2.4.7. Biopharmaceuticals Market size and forecast, by region
      • 5.2.4.8. Biopharmaceuticals Market size and forecast, by country
  • 5.3. Biotechnology
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
    • 5.3.4. Biotechnology Yeast Extract Market by Sub-type
      • 5.3.4.1. Cell Culture Media Market size and forecast, by region
      • 5.3.4.2. Cell Culture Media Market size and forecast, by country
      • 5.3.4.3. Enzyme Production Market size and forecast, by region
      • 5.3.4.4. Enzyme Production Market size and forecast, by country

CHAPTER 6: YEAST EXTRACT MARKET, BY FORM

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Liquid
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Dry
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: YEAST EXTRACT MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Application
      • 7.2.3.1. North America Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.2.3.2. North America Biotechnology Yeast Extract Market by Sub-type
    • 7.2.4. Market size and forecast, by Form
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Type
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.2.1. U.S. Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.2.5.1.2.2. U.S. Biotechnology Yeast Extract Market by Sub-type
      • 7.2.5.1.3. Market size and forecast, by Form
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Type
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.2.1. Canada Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.2.5.2.2.2. Canada Biotechnology Yeast Extract Market by Sub-type
      • 7.2.5.2.3. Market size and forecast, by Form
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Type
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.2.1. Mexico Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.2.5.3.2.2. Mexico Biotechnology Yeast Extract Market by Sub-type
      • 7.2.5.3.3. Market size and forecast, by Form
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Application
      • 7.3.3.1. Europe Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.3.2. Europe Biotechnology Yeast Extract Market by Sub-type
    • 7.3.4. Market size and forecast, by Form
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. France
      • 7.3.5.1.1. Market size and forecast, by Type
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.2.1. France Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.1.2.2. France Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.1.3. Market size and forecast, by Form
      • 7.3.5.2. Germany
      • 7.3.5.2.1. Market size and forecast, by Type
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.2.1. Germany Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.2.2.2. Germany Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.2.3. Market size and forecast, by Form
      • 7.3.5.3. Italy
      • 7.3.5.3.1. Market size and forecast, by Type
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.2.1. Italy Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.3.2.2. Italy Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.3.3. Market size and forecast, by Form
      • 7.3.5.4. Spain
      • 7.3.5.4.1. Market size and forecast, by Type
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.2.1. Spain Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.4.2.2. Spain Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.4.3. Market size and forecast, by Form
      • 7.3.5.5. UK
      • 7.3.5.5.1. Market size and forecast, by Type
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.2.1. UK Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.5.2.2. UK Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.5.3. Market size and forecast, by Form
      • 7.3.5.6. Russia
      • 7.3.5.6.1. Market size and forecast, by Type
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.2.1. Russia Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.6.2.2. Russia Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.6.3. Market size and forecast, by Form
      • 7.3.5.7. Rest of Europe
      • 7.3.5.7.1. Market size and forecast, by Type
      • 7.3.5.7.2. Market size and forecast, by Application
      • 7.3.5.7.2.1. Rest of Europe Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.3.5.7.2.2. Rest of Europe Biotechnology Yeast Extract Market by Sub-type
      • 7.3.5.7.3. Market size and forecast, by Form
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Application
      • 7.4.3.1. Asia-Pacific Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.3.2. Asia-Pacific Biotechnology Yeast Extract Market by Sub-type
    • 7.4.4. Market size and forecast, by Form
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. China
      • 7.4.5.1.1. Market size and forecast, by Type
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.2.1. China Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.1.2.2. China Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.1.3. Market size and forecast, by Form
      • 7.4.5.2. Japan
      • 7.4.5.2.1. Market size and forecast, by Type
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.2.1. Japan Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.2.2.2. Japan Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.2.3. Market size and forecast, by Form
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Type
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.2.1. India Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.3.2.2. India Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.3.3. Market size and forecast, by Form
      • 7.4.5.4. South Korea
      • 7.4.5.4.1. Market size and forecast, by Type
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.2.1. South Korea Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.4.2.2. South Korea Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.4.3. Market size and forecast, by Form
      • 7.4.5.5. Australia
      • 7.4.5.5.1. Market size and forecast, by Type
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.2.1. Australia Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.5.2.2. Australia Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.5.3. Market size and forecast, by Form
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Type
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.2.1. Rest of Asia-Pacific Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.4.5.6.2.2. Rest of Asia-Pacific Biotechnology Yeast Extract Market by Sub-type
      • 7.4.5.6.3. Market size and forecast, by Form
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Application
      • 7.5.3.1. LAMEA Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.3.2. LAMEA Biotechnology Yeast Extract Market by Sub-type
    • 7.5.4. Market size and forecast, by Form
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Type
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.2.1. Brazil Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.1.2.2. Brazil Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.1.3. Market size and forecast, by Form
      • 7.5.5.2. South Africa,
      • 7.5.5.2.1. Market size and forecast, by Type
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.2.1. South Africa, Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.2.2.2. South Africa, Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.2.3. Market size and forecast, by Form
      • 7.5.5.3. Saudi Arabia
      • 7.5.5.3.1. Market size and forecast, by Type
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.2.1. Saudi Arabia Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.3.2.2. Saudi Arabia Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.3.3. Market size and forecast, by Form
      • 7.5.5.4. UAE
      • 7.5.5.4.1. Market size and forecast, by Type
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.2.1. UAE Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.4.2.2. UAE Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.4.3. Market size and forecast, by Form
      • 7.5.5.5. Argentina
      • 7.5.5.5.1. Market size and forecast, by Type
      • 7.5.5.5.2. Market size and forecast, by Application
      • 7.5.5.5.2.1. Argentina Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.5.2.2. Argentina Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.5.3. Market size and forecast, by Form
      • 7.5.5.6. Rest of LAMEA
      • 7.5.5.6.1. Market size and forecast, by Type
      • 7.5.5.6.2. Market size and forecast, by Application
      • 7.5.5.6.2.1. Rest of LAMEA Pharmaceuticals Yeast Extract Market by Sub-type
      • 7.5.5.6.2.2. Rest of LAMEA Biotechnology Yeast Extract Market by Sub-type
      • 7.5.5.6.3. Market size and forecast, by Form

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. LESAFFRE GROUP
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Key strategic moves and developments
  • 9.2. Kerry Group
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Lallemand Inc.
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. AngelYeast Co., Ltd.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Key strategic moves and developments
  • 9.5. Associated British Foods PLC
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. Thermo Fisher Scientific Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
  • 9.7. VWR International, LLC.
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. Merck KGaA
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
  • 9.9. CELLSECO LTD.
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. FUJIFILM Irvine Scientific
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
  • 9.11. Nu-Tek BioSciences
    • 9.11.1. Company overview
    • 9.11.2. Key executives
    • 9.11.3. Company snapshot
    • 9.11.4. Operating business segments
    • 9.11.5. Product portfolio